These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147 [TBL] [Abstract][Full Text] [Related]
5. Detection of BRAF V600E mutation in thyroid fine-needle aspiration specimens by High Resolution Melting (HRM) analysis. Nechifor-Boilă A; Decaussin-Petrucci M; Gazzo S; Paşcanu I; Borda A Rom J Morphol Embryol; 2012; 53(2):263-7. PubMed ID: 22732794 [TBL] [Abstract][Full Text] [Related]
6. Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience. Rossi ED; Bizzarro T; Martini M; Capodimonti S; Fadda G; Larocca LM; Schmitt F Cancer Cytopathol; 2014 Dec; 122(12):883-91. PubMed ID: 25156883 [TBL] [Abstract][Full Text] [Related]
7. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma. Chang H; Lee H; Yoon SO; Kim H; Kim A; Kim BH Hum Pathol; 2012 Jan; 43(1):89-95. PubMed ID: 21774961 [TBL] [Abstract][Full Text] [Related]
8. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165 [TBL] [Abstract][Full Text] [Related]
9. BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR. Jeong D; Jeong Y; Park JH; Han SW; Kim SY; Kim YJ; Kim SJ; Hwangbo Y; Park S; Cho HD; Oh MH; Yang SH; Kim CJ Ann Surg Oncol; 2013 Mar; 20(3):759-66. PubMed ID: 23179992 [TBL] [Abstract][Full Text] [Related]
10. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid Rodolico V; Cabibi D; Pizzolanti G; Richiusa P; Gebbia N; Martorana A; Russo A; Amato MC; Galluzzo A; Giordano C Cancer; 2007 Sep; 110(6):1218-26. PubMed ID: 17685465 [TBL] [Abstract][Full Text] [Related]
11. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358 [TBL] [Abstract][Full Text] [Related]
13. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Jin L; Sebo TJ; Nakamura N; Qian X; Oliveira A; Majerus JA; Johnson MR; Lloyd RV Diagn Mol Pathol; 2006 Sep; 15(3):136-43. PubMed ID: 16932068 [TBL] [Abstract][Full Text] [Related]
14. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. Trovisco V; Vieira de Castro I; Soares P; Máximo V; Silva P; Magalhães J; Abrosimov A; Guiu XM; Sobrinho-Simões M J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508 [TBL] [Abstract][Full Text] [Related]
15. BRAF(V600E) mutation and the biology of papillary thyroid cancer. Frasca F; Nucera C; Pellegriti G; Gangemi P; Attard M; Stella M; Loda M; Vella V; Giordano C; Trimarchi F; Mazzon E; Belfiore A; Vigneri R Endocr Relat Cancer; 2008 Mar; 15(1):191-205. PubMed ID: 18310287 [TBL] [Abstract][Full Text] [Related]
16. [BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens]. Dujardin F; Pagès JC; Collin C; de Calan L; Lecomte P; Guyétant S Ann Pathol; 2010 Aug; 30(4):252-62. PubMed ID: 20837233 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas. Nakayama H; Yoshida A; Nakamura Y; Hayashi H; Miyagi Y; Wada N; Rino Y; Masuda M; Imada T Anticancer Res; 2007; 27(5B):3645-9. PubMed ID: 17972530 [TBL] [Abstract][Full Text] [Related]
18. The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome? Walczyk A; Kowalska A; Kowalik A; Sygut J; Wypiórkiewicz E; Chodurska R; Pięciak L; Góźdź S Clin Endocrinol (Oxf); 2014 Jun; 80(6):899-904. PubMed ID: 24354346 [TBL] [Abstract][Full Text] [Related]
19. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470 [TBL] [Abstract][Full Text] [Related]
20. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study. Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]